BioInformant

Your Global Leader in Stem Cell Market Research

Home » cell therapy » Page 2

What Are Stem Cells Used For

By 1 Comment

What are stem cells used for? There are many potential uses for stem cells, from the treatment of cancer to chronic conditions, acute injuries and more. Scientists continue to perform research on stem cells to maximize their therapeutic benefits and possible contributions to the medical industry.

In this article:

What Are Stem Cells Used For? | Some FAQs Answered

While stem cells are important for treating people with major health issues, they are also advancing new frontiers in healthcare. [Read more…]

Mesenchymal Stem Cells Review | Future of MSC Therapy

By 1 Comment

In this article, Dr. Daniel Kota provides a mesenchymal stem cell review and explores the future of MSC therapy. Mesenchymal stem cells (MSCs) are multipotent cells that prefer to differentiate into cells of the musculoskeletal system, such as bone, cartilage, muscle and fat cells. However, MSCs can also be induced to become other cell types, as well as exert therapeutic effects by honing to sites of repair and secreting therapeutic agents.

In this article:

Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility

By Leave a Comment

  • First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases

  • With 300,000 square feet (27,870 square meters), it is the largest dedicated cell-and-gene-therapy manufacturing facility in the world

  • Facility to reach 200 full-time staff by end of 2018 and continue to recruit high-value positions as market demand increases

[Read more…]

SanBio’s Regenerative Medicine Product SB623 to Be Manufactured by Hitachi Chemical

By Leave a Comment

March 13, 2018 03:39, TOKYO — SanBio Group and Hitachi Chemical Co., Ltd. (Hitachi Chemical) jointly announced today that, through an agreement with Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS; formerly PCT Cell Therapy Services, LLC), Hitachi Chemical’s US subsidiary that engages in contract manufacturing and development of regenerative medicine products*1, they will manufacture SB623, a proprietary regenerative medicine product under development by SanBio. Under the agreement, late stage clinical products and commercial products of SB623 for the US and Japanese markets will be manufactured using Hitachi Chemical’s global facilities. [Read more…]

Cytori Completes Enrollment for Habeo™ Cell Therapy for Scleroderma and Impaired Hand Function

By Leave a Comment

  • Cytori developing cell therapies that harness the unique attributes of adipose-derived regenerative cells (ADRCs)

  • 40 patients enrolled among 5 French centers: Marseille, Montpelier, Rouen, Lyon, and Paris

SAN DIEGO, Jan. 22, 2018 — Cytori Therapeutics, Inc. (NASDAQ:CYTX) announces completion of patient enrollment in SCLERADEC II (NCT02558543), a randomized, double-blind, placebo-controlled, parallel group, multi-center clinical trial intended to study the safety and efficacy of Habeo™ Cell Therapy in up to 40 subjects with impaired hand function due to scleroderma (systemic sclerosis). [Read more…]

BioInformant's World-Class Clients

Shopping cart0
There are no products in the cart!
Continue shopping
0